Postoperative readmissions following ileostomy formation among patients with a gynecologic malignancy

Por Glasgow, Michelle A., Shields, Kristin, Isaksson Vogel, Rachel, Teoh, Deanna, Argenta, Peter A.
Publicado no Gynecol Oncol (2014)

The effect of anesthesia choice on post-operative outcomes in women undergoing exploratory laparotomy for a suspected gynecologic malignancy()

Por Rivard, Colleen, Dickson, Elizabeth L, Vogel, Rachel Isaksson, Argenta, Peter A., Teoh, Deanna
Publicado no Gynecol Oncol (2014)

Genetic Risk Assessment for Women with Epithelial Ovarian Cancer: Referral Patterns and Outcomes in a University Gynecologic Oncology Clinic

Por Petzel, Sue V., Vogel, Rachel Isaksson, Bensend, Tracy, Leininger, Anna, Argenta, Peter A., Geller, Melissa A.
Publicado no J Genet Couns (2013)

Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system

Por Petzel, Sue V., Vogel, Rachel Isaksson, McNiel, Jena, Leininger, Anna, Argenta, Peter A., Geller, Melissa A.
Publicado no Int J Gynecol Cancer (2014)

Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells

Por Diep, Caroline H., Charles, Nathan J., Gilks, C. Blake, Kalloger, Steve E., Argenta, Peter A., Lange, Carol A.
Publicado em 2013

Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17

Por Buchanan, Petra C., Boylan, Kristin L. M., Walcheck, Bruce, Heinze, Rachel, Geller, Melissa A., Argenta, Peter A., Skubitz, Amy P. N.
Publicado no J Biol Chem (2017)

A prospective, randomized trial of integrative medicine for women with ovarian cancer(,)

Por Judson, Patricia L., Dickson, Elizabeth L., Argenta, Peter A., Xiong, Yin, Geller, Melissa A., Carson, Linda F., Ghebre, Rahel, Jonson, Amy L., Downs, Levi S.
Publicado em 2011

S100A1 Expression in Ovarian and Endometrial Endometrioid Carcinomas Is a Prognostic Indicator of Relapse-Free Survival

Por DeRycke, Melissa S., Andersen, John D., Harrington, Katherine M., Pambuccian, Stefan E., Kalloger, Steve E., Boylan, Kristin L.M., Argenta, Peter A., Skubitz, Amy P.N.
Publicado em 2009

Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers

Por Geller, Melissa A., Cooley, Sarah, Argenta, Peter A., Downs, Levi S., Carson, Linda F., Judson, Patricia L., Ghebre, Rahel, Weigel, Brenda, Panoskaltsis-Mortari, Angela, Curtsinger, Julie, Miller, Jeffrey S.
Publicado em 2010

Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum: Potential Role as a Serum Biomarker

Por DeRycke, Melissa S., Pambuccian, Stefan E., Gilks, C. Blake, Kalloger, Steve E., Ghidouche, Abderrezak, Lopez, Marc, Bliss, Robin L., Geller, Melissa A., Argenta, Peter A., Harrington, Katherine M., Skubitz, Amy P.N.
Publicado em 2010

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

Por Geller, Melissa A., Cooley, Sarah, Judson, Patricia L., Ghebre, Rahel, Carson, Linda F., Argenta, Peter A., Jonson, Amy L., Panoskaltsis-Mortari, Angela, Curtsinger, Julie, McKenna, David, Dusenbery, Kathryn, Bliss, Robin, Downs, Levi S., Miller, Jeffrey S.
Publicado em 2010

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

Por Bookman, Michael A., Brady, Mark F., McGuire, William P., Harper, Peter G., Alberts, David S., Friedlander, Michael, Colombo, Nicoletta, Fowler, Jeffrey M., Argenta, Peter A., De Geest, Koen, Mutch, David G., Burger, Robert A., Swart, Ann Marie, Trimble, Edward L., Accario-Winslow, Chrisann, Roth, Lawrence M.
Publicado em 2009

Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group st...

Por Devor, Eric J, Miecznikowski, Jeffrey, Schickling, Brandon M, Gonzalez-Bosquet, Jesus, Lankes, Heather A, Thaker, Premal, Argenta, Peter A, Pearl, Michael L, Zweizig, Susan L, Mannel, Robert S, Brown, Amy, Ramirez, Nilsa C, Ioffe, Olga B, Park, Kay J, Creasman, William T, Birrer, Michael J, Mutch, David, Leslie, Kimberly K.
Publicado no Gynecol Oncol (2017)

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol()

Por Creasman, William T., Ali, Shamshad, Mutch, David G., Zaino, Richard J., Powell, Matthew A., Mannel, Robert S., Backes, Floor J., DiSilvestro, Paul A., Argenta, Peter A., Pearl, Michael L., Lele, Shashikant B., Guntupalli, Saketh R., Waggoner, Steven, Spirtos, Nick, Boggess, John F., Edwards, Robert P., Filiaci, Virginia L., Miller, David S.
Publicado no Gynecol Oncol (2017)

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG O...

Por Oliver, Kate E, Brady, William E, Birrer, Michael, Gershenson, David M, Fleming, Gini, Copeland, Larry J, Tewari, Krishnansu, Argenta, Peter A, Mannel, Robert S, Secord, Angeles Alvarez, Stephan, Jean-Marie, Mutch, David G, Stehman, Frederick B, Muggia, Franco M, Rose, Peter G, Armstrong, Deborah K, Bookman, Michael A, Burger, Robert A, Farley, John H.
Publicado no Gynecol Oncol (2017)